Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
CC transcript
Credit agrmnt [a]
Acq. announced
Appointed director
|
|
IMPAX LABORATORIES INC (IPXL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2018 |
4
| Vergis Janet S. (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 6,642 shares
@ $0
Disposed/sold 5,508 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 8,100 options to buy
@ $38.42, valued at
$311.2k
|
|
| 05/08/2018 |
4
| TERRERI PETER R (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 43,129 shares
@ $0
Disposed/sold 5,408 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 7,300 options to buy
@ $44.85, valued at
$327.4k
Disposed/sold 11,500 options to buy
@ $25.24, valued at
$290.3k
Disposed/sold 12,000 options to buy
@ $17.99, valued at
$215.9k
Disposed/sold 10,000 options to buy
@ $20.9, valued at
$209k
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 10,000 options to buy
@ $20.3, valued at
$203k
Disposed/sold 45,000 options to buy
@ $6.55, valued at
$294.8k
|
|
| 05/08/2018 |
4
| PENDERGAST MARY K (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 16,942 shares
@ $0
Disposed/sold 5,408 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 7,300 options to buy
@ $44.85, valued at
$327.4k
Disposed/sold 11,500 options to buy
@ $25.24, valued at
$290.3k
Disposed/sold 12,000 options to buy
@ $20.36, valued at
$244.3k
|
|
| 05/08/2018 |
4
| CHAO ALLEN (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 64,037 shares
@ $0
Disposed/sold 20,000 shares
@ $0
Disposed/sold 180,000 shares
@ $0
Disposed/sold 116,000 shares
@ $0
Disposed/sold 5,408 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 7,300 options to buy
@ $44.85, valued at
$327.4k
Disposed/sold 11,500 options to buy
@ $25.24, valued at
$290.3k
Disposed/sold 12,000 options to buy
@ $17.99, valued at
$215.9k
Disposed/sold 10,000 options to buy
@ $20.9, valued at
$209k
|
|
| 05/08/2018 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 8,020 shares
@ $0
Disposed/sold 3,281 shares
@ $0
Disposed/sold 7,931 options to buy
@ $16.4, valued at
$130.1k
Disposed/sold 20,445 options to buy
@ $14.45, valued at
$295.4k
|
|
| 05/08/2018 |
4
| BENET LESLIE Z (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 17,741 shares
@ $0
Disposed/sold 600 shares
@ $0
Disposed/sold 4,742 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 12,000 options to buy
@ $44.85, valued at
$538.2k
Disposed/sold 2,750 options to buy
@ $35.89, valued at
$98.7k
Disposed/sold 19,600 options to buy
@ $25.24, valued at
$494.7k
Disposed/sold 25,000 options to buy
@ $17.99, valued at
$449.8k
Disposed/sold 16,000 options to buy
@ $20.9, valued at
$334.4k
Disposed/sold 19,000 options to buy
@ $27.97, valued at
$531.4k
|
|
| 05/08/2018 |
4
| BURR ROBERT L (Director) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 55,067 shares
@ $0
Disposed/sold 6,057 shares
@ $0
Disposed/sold 5,408 shares
@ $0
Disposed/sold 10,575 options to buy
@ $16.4, valued at
$173.4k
Disposed/sold 10,575 options to buy
@ $30.33, valued at
$320.7k
Disposed/sold 7,300 options to buy
@ $44.85, valued at
$327.4k
Disposed/sold 11,500 options to buy
@ $25.24, valued at
$290.3k
Disposed/sold 12,000 options to buy
@ $17.99, valued at
$215.9k
Disposed/sold 10,000 options to buy
@ $20.9, valued at
$209k
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 10,000 options to buy
@ $20.3, valued at
$203k
|
|
| 05/08/2018 |
4
| Nornhold Jeffrey (SVP, Technical Operations) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 54,043 shares
@ $0
Disposed/sold 11,835 shares
@ $0
Disposed/sold 41,842 options to buy
@ $9.35, valued at
$391.2k
Disposed/sold 41,842 options to buy
@ $33.27, valued at
$1.4M
Disposed/sold 28,500 options to buy
@ $40.7, valued at
$1.2M
Disposed/sold 55,000 options to buy
@ $25.24, valued at
$1.4M
|
|
| 05/08/2018 |
4
| SCHLOSSBERG MARK A (SVP and General Counsel) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 50,116 shares
@ $0
Disposed/sold 18,135 shares
@ $0
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
Disposed/sold 52,801 options to buy
@ $33.27, valued at
$1.8M
Disposed/sold 47,500 options to buy
@ $40.7, valued at
$1.9M
Disposed/sold 55,000 options to buy
@ $25.24, valued at
$1.4M
Disposed/sold 52,000 options to buy
@ $17.99, valued at
$935.5k
Disposed/sold 21,667 options to buy
@ $20.9, valued at
$452.8k
Disposed/sold 100,000 options to buy
@ $21.24, valued at
$2.1M
|
|
| 05/08/2018 |
4
| NESTOR MICHAEL (President, Impax Specialty) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 56,796 shares
@ $0
Disposed/sold 19,728 shares
@ $0
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
Disposed/sold 52,801 options to buy
@ $33.27, valued at
$1.8M
Disposed/sold 47,500 options to buy
@ $40.7, valued at
$1.9M
Disposed/sold 55,000 options to buy
@ $25.24, valued at
$1.4M
Disposed/sold 52,000 options to buy
@ $17.99, valued at
$935.5k
Disposed/sold 32,500 options to buy
@ $20.9, valued at
$679.3k
Disposed/sold 32,500 options to buy
@ $27.97, valued at
$909k
Disposed/sold 32,500 options to buy
@ $20.3, valued at
$659.8k
Disposed/sold 16,250 options to buy
@ $6.55, valued at
$106.4k
|
|
| 05/08/2018 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 14,145 shares
@ $0
Disposed/sold 41,756 shares
@ $0
Disposed/sold 50,500 options to buy
@ $24.42, valued at
$1.2M
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
|
|
| 05/08/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 53,423 shares
@ $0
Disposed/sold 20,566 shares
@ $0
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
Disposed/sold 63,095 options to buy
@ $33.27, valued at
$2.1M
Disposed/sold 47,500 options to buy
@ $40.7, valued at
$1.9M
Disposed/sold 55,000 options to buy
@ $25.24, valued at
$1.4M
Disposed/sold 52,000 options to buy
@ $17.99, valued at
$935.5k
|
|
| 05/08/2018 |
4
| BISARO PAUL (President and CEO) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 850,000 options to buy
@ $12.7, valued at
$10.8M
|
|
| 03/05/2018 |
4
| Nornhold Jeffrey (SVP, Technical Operations) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 2,436 shares
@ $19.5, valued at
$47.5k
|
|
| 03/05/2018 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 2,041 shares
@ $19.5, valued at
$39.8k
|
|
| 03/05/2018 |
4
| SCHLOSSBERG MARK A (SVP and General Counsel) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 3,273 shares
@ $19.5, valued at
$63.8k
|
|
| 03/05/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 3,069 shares
@ $19.5, valued at
$59.8k
|
|
| 02/27/2018 |
4
| Nornhold Jeffrey (SVP, Technical Operations) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 4,215 shares
@ $20.95, valued at
$88.3k
|
|
| 02/27/2018 |
4
| NESTOR MICHAEL (President, Impax Specialty) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 5,547 shares
@ $20.95, valued at
$116.2k
|
|
| 02/27/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 6,141 shares
@ $20.95, valued at
$128.7k
|
|
| 02/27/2018 |
4
| SCHLOSSBERG MARK A (SVP and General Counsel) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 5,937 shares
@ $20.95, valued at
$124.4k
|
|
| 10/26/2017 |
4
| Nornhold Jeffrey (SVP, Technical Operations) has filed a Form 4 on IMPAX LABORATORIES INC |
| 08/02/2017 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 5,282 shares
@ $17.85, valued at
$94.3k
|
|
| 06/01/2017 |
4
| NESTOR MICHAEL (President, Impax Specialty) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Sold 1,130 shares
@ $15, valued at
$17k
|
|
| 05/17/2017 |
4
| NESTOR MICHAEL (President, Impax Specialty) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Sold 857 shares
@ $16.475, valued at
$14.1k
|
|
| 05/17/2017 |
4
| TERRERI PETER R (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/17/2017 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 3,281 shares
@ $0
Granted 7,931 options to buy
@ $16.4, valued at
$130.1k
|
|
| 05/17/2017 |
4
| BENET LESLIE Z (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/17/2017 |
4
| PENDERGAST MARY K (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2017 |
4
| Bierly Rick (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/17/2017 |
4
| Vergis Janet S. (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/17/2017 |
4
| BURR ROBERT L (Director) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,375 shares
@ $0
Granted 10,575 options to buy
@ $16.4, valued at
$173.4k
|
|
| 05/16/2017 |
4
| Nornhold Jeffrey (SVP, Technical Operations) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 502 shares
@ $17.65, valued at
$8.9k
|
|
|
|
|